CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project develops a novel technology for continuous glucose monitoring in intensive care unit patients. This minimally invasive solution aims to improve glucose control, potentially saving lives and reducing hospital costs. It addresses a critical gap, as existing devices for diabetics are ineffective in ICU setting…
9 of 10 intensive care unit (ICU) patients get elevated glucose levels because of their critical illness.
Clinical trials prove that better glucose control could save thousands of lives and millions of euros for hospitals.
Surprisingly, no continuous glucose monitor (CGM) is available for ICU patients, as solutions developed for diabetics don't work in the ICU.GlucoSet has a novel, patented technology for glucose monitoring.
This enables - for the first time - reliable, minimally invasive, real-…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
